Home › Neuroblastoma

Neuroblastoma klinische studies rekruteren in de VS

47 studies voor Neuroblastoma rekruteren deelnemers op locaties doorheen de Verenigde Staten.

Steden met de meeste studies

• Boston, MA13 studies
• Washington, DC11 studies
• New York City, NY10 studies
• Memphis, TN9 studies
• Dallas, TX9 studies
• Philadelphia, PA9 studies
• St. Louis, MO9 studies
• Aurora, CO8 studies
• Hartford, CT8 studies
• Minneapolis, MN8 studies
• Birmingham, AL8 studies
• Atlanta, GA7 studies
• Cincinnati, OH7 studies
• Los Angeles, CA7 studies
• San Francisco, CA7 studies
• Houston, TX7 studies
• Orlando, FL7 studies
• Miami, FL7 studies
• Seattle, WA6 studies
• Chicago, IL6 studies
• Durham, NC6 studies
• Salt Lake City, UT6 studies
• Gainesville, FL6 studies
• Honolulu, HI6 studies
• Little Rock, AR6 studies
• Portland, OR6 studies
• Greenburgh, NY6 studies
• Harrisburg, PA6 studies
• Columbus, OH5 studies
• Ann Arbor, MI5 studies
• Mountain View, CA5 studies
• Austin, TX5 studies
• San Diego, CA5 studies
• Nashville, TN5 studies
• Oakland, CA5 studies
• Fort Worth, TX4 studies
• Madison, WI4 studies
• Charlotte, NC4 studies
• Edison, NJ4 studies
• Charleston, SC4 studies

Per staat

• Alabama8 studies
• Arizona3 studies
• Arkansas6 studies
• Californië14 studies
• Colorado8 studies
• Connecticut9 studies
• District of Columbia6 studies
• Florida9 studies
• Georgia9 studies
• Hawaï6 studies
• Illinois6 studies
• Indiana3 studies
• Iowa3 studies
• Kentucky5 studies
• Maryland8 studies
• Massachusetts13 studies
• Michigan8 studies
• Minnesota9 studies
• Missouri10 studies
• New Jersey6 studies
• New York13 studies
• North Carolina7 studies
• North Dakota3 studies
• Ohio8 studies
• Oregon6 studies
• Pennsylvania14 studies
• Rhode Island3 studies
• South Carolina4 studies
• South Dakota3 studies
• Tennessee12 studies
• Texas15 studies
• Utah6 studies
• Virginia3 studies
• Washington6 studies
• Wisconsin4 studies

Recent bijgewerkte studies

Officiële studietekst (Engels)

Van ClinicalTrials.gov, gegevens opgehaald op 3 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.